Phibro Animal Health Corporation (PAHC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.46B
Last updated: Nov 17, 2026 at 11:04 AM ET
Phibro Animal Health Corporation (PAHC) Stock Forecast
Analysts expect Phibro Animal Health (PAHC) to earn $3.48 per share in the fiscal year ending Jun 30, 2027, on revenue of $1.58B. Of 3 analysts, 1 rates the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.33, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 33% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 0 | 0.0% |
| Hold | 2 | 66.7% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 11.5% and revenue estimates rise 3.2%.
- Fiscal year ending Jun 30, 2027
- $3.48
- EPS consensus, revenue $1.58B
- Fiscal year ending Jun 30, 2028
- $3.88
- EPS consensus, revenue $1.63B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jun 30, 2027 | $3.48 | $3.47 to $3.50 | 3 | $1.58B | $1.57B to $1.59B | 3 |
| Jun 30, 2028 | $3.88 | $3.75 to $4.06 | 3 | $1.63B | $1.62B to $1.65B | 3 |
Quarterly Estimates
Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Mar 31, 2027, at $0.87, and highest for the quarter ending Dec 31, 2026, at $0.94.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.94 | $0.91 to $0.97 | 2 | $402.00M | $402.00M to $402.00M | 1 |
| Mar 31, 2027 | $0.87 | $0.84 to $0.89 | 2 | $397.00M | $397.00M to $397.00M | 1 |
| Jun 30, 2027 | $0.91 | $0.86 to $0.96 | 4 | $411.06M | $394.94M to $423.15M | 3 |
Estimate Revisions
Across the 4 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jun 30, 2027 | 1 | 0 |
| Fiscal year ending Jun 30, 2028 | 1 | 0 |
| Quarter ending Dec 31, 2026 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Jun 30, 2027 has risen 4.2% from $3.34.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Jun 30, 2027 | $3.48 | $3.50 | $3.50 | $3.50 | $3.34 | +4.1% |
| Fiscal year ending Jun 30, 2028 | $3.88 | $3.85 | $3.84 | $3.85 | $3.69 | +5.3% |
| Quarter ending Dec 31, 2026 | $0.94 | $0.94 | $0.99 | $0.97 | $0.91 | +3.0% |
| Quarter ending Mar 31, 2027 | $0.87 | $0.88 | $0.85 | $0.86 | $0.80 | +8.4% |
Frequently Asked Questions About PAHC
What is the PAHC stock forecast?
Consensus analyst estimates put Phibro Animal Health's EPS at $3.48 for the fiscal year ending Jun 30, 2027, on revenue of $1.58B. The consensus rating from 3 analysts is Buy.
How do analysts rate PAHC stock?
Of 3 analysts covering Phibro Animal Health, 1 rates it Strong Buy, 0 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PAHC next year?
For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is $3.48, with estimates from $3.47 to $3.50 from 3 analysts. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is $3.88, with estimates from $3.75 to $4.06 from 3 analysts.
What revenue do analysts expect from Phibro Animal Health next year?
For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $1.58B, with estimates from $1.57B to $1.59B. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $1.63B, with estimates from $1.62B to $1.65B.
How many analysts cover PAHC?
3 analysts rate Phibro Animal Health stock, and 3 analysts estimate its EPS for the fiscal year ending Jun 30, 2027.
PAHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors